Cancer Collaboration

Sunil Hingorani, MD, Ph.D

Dr. Hingorani is a Professor in the Division of Oncology and Hematology at the University of Nebraska Medical Center (UNMC) and Buffett Cancer Center UNMC and serves as the inaugural Director of the Pancreatic Cancer Center of Excellence (PCCE). The PCCE will unite and colocalize basic science researchers, translational research, and clinicians in a comprehensive effort to develop early detection, chemoprevention, and treatment strategies for this devastating disease. Previously, Dr. Hingorani was Professor and Raisbeck Endowed Chair for Pancreatic Research at Fred Hutchinson Cancer Research Center and University of Washington School of Medicine. He received a BS in Molecular Biophysics and Biochemistry from Yale College and a PhD in Cellular and Molecular Physiology and an MD from Yale University. He completed a fellowship in Hematology and Oncology at Dana-Farber Cancer Institute in Boston and postdoctoral research at MIT.

Lynn Matrisian, Ph.D, MBA

As Chief Science Officer at Pancreatic Action Network, Dr. Lynn Matrisian brings extensive experience and passion for cancer research, combined with business training, to provide strategic direction for the scientific aspects of the initiatives and activities within the Scientific & Medical Affairs team toward the goal of improving outcomes for those facing pancreatic cancer. She received a PhD in molecular biology from the University of Arizona and an MBA from the Owen Graduate School of Management at Vanderbilt University.

Theresa LaValle, Ph.D

Dr. LaVallee is currently the Chief Development Officer at Coherus BioScienses. She brings more than 25 years of drug discovery and development experience. Most recently, Dr. LaVallee was Vice President, Translational Medicine and Regulatory Affairs at the Parker Institute for Cancer Immunotherapy where she provided scientific leadership for clinical strategy for development of novel immuno-oncology therapies and helped establish the institute's clinical, translational and regulatory organization. She earned her Ph.D. from the University of California, Los Angeles and her bachelor's degree from the University of California, Santa Barbara.

Canopy Cancer Collective improves collaboration among leading healthcare systems to drive innovation, elevate engagement, and empower patients with hope. Adopting a comprehensive multidisciplinary approach, the nonprofit works with top medical care providers, cancer researchers, and wellness specialists to ensure patients never get lost in the system. Canopy Cancer Collective aims to help cancer centers deliver comprehensive, coordinated, and more effective care to the pancreatic patient. Interested healthcare systems are encouraged to apply.  An additional six cohort partners will be selected to participate in 2021. For more information, or to connect with a Canopy Cancer Collective representative click here: https://canopycancer.org/contact

Like Wikipedia and Yelp, this public database of clinical trial information enables anyone to annotate, structure, and rate trials while providing improved search tools. ClinWiki provides transparent and relevant views of trials for patients and their physicians so they can find and choose the best options. The goal is to surface more relevant results and increase innovation. The nonprofit is based in Chapel Hill, North Carolina, using open source software and crowd-sourced data.

Damon Runyon Cancer Research Foundation funds high-risk and high-reward cancer research. The foundation identifies and enables young scientists who are brilliant, brave, and bold enough to go where others haven't. Their goal is to foster the talent capable of revolutionizing the prevention, detection, and treatment of all forms of cancer. Their scientists lead major research organizations and academic institutions around the world and have developed new treatments that are saving countless lives. Some of their scientists have received the highest honors and awards including, 12 Nobel Prizes, 7 National Medals of Science (highest scientific honor in USA), 86 elected to the National Academy of Sciences (science "Hall of Fame"), 37 Members of the National Academy of Medicine, and 15 Lasker Awards.

The Seattle-based nonprofit's mission is to prevent, diagnose and treat cancer and related diseases. Researchers bring a relentless passion to their work and deliver hope to patients who come from all over the world. Interdisciplinary teams are working to detect cancers earlier, when cure rates are highest; developing effective treatments with fewer side effects; and learning how to prevent cancers from developing in the first place. Fred Hutch scientists at the Hingorani laboratory investigate the molecular and cellular mechanisms that drive the pathogenesis of pancreas cancer.

Founded in 1999, the Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world's toughest cancer. They attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Their efforts are amplified by a nationwide grassroots support network. PanCAN's goal is to improve patient outcomes today and to double survival. If you have pancreatic cancer, or know someone with it, PanCAN is a great resource to augment your current care team.

The Parker Institute for Cancer Immunotherapy is radically changing the way research is done. Our model is designed to remove barriers, amplify collaborations and accelerate the development of immune therapies to make all cancers curable. We bring together the top minds in the field. We fuel the boldest ideas. And we give our researchers the highest class tools and resources to do the best science. At PICI, success doesn't mean we'll never worry about cancer again. It means we won't have to fear it.